David Baldwin

14.9k total citations · 4 hit papers
229 papers, 7.4k citations indexed

About

David Baldwin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Baldwin has authored 229 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 180 papers in Pulmonary and Respiratory Medicine, 68 papers in Oncology and 53 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Baldwin's work include Lung Cancer Diagnosis and Treatment (136 papers), Lung Cancer Treatments and Mutations (75 papers) and Global Cancer Incidence and Screening (48 papers). David Baldwin is often cited by papers focused on Lung Cancer Diagnosis and Treatment (136 papers), Lung Cancer Treatments and Mutations (75 papers) and Global Cancer Incidence and Screening (48 papers). David Baldwin collaborates with scholars based in United Kingdom, United States and Netherlands. David Baldwin's co-authors include Matthew Callister, D. Honeybourne, G. Jones, Robert A. Wise, Richard Hubbard, Laila J. Tata, Stephen W. Duffy, John K. Field, Helen Powell and Anand Devaraj and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Baldwin

218 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE

2015 604 citations Matthew Callister, David Baldwin et al. Thorax profile →
The British Thoracic Society guidelines on the investigation and management of pulmonary nodules

2015 544 citations David Baldwin, Matthew Callister Thorax profile →
Recent advances in the management of lung cancer

2018 325 citations David Baldwin et al. profile →
Lung cancer screening

2022 228 citations David Baldwin et al. profile →

Peers

Countries citing papers authored by David Baldwin

Since Specialization

Citations

This map shows the geographic impact of David Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Baldwin more than expected).

Fields of papers citing papers by David Baldwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Baldwin. The network helps show where David Baldwin may publish in the future.

Co-authorship network of co-authors of David Baldwin

This figure shows the co-authorship network connecting the top 25 collaborators of David Baldwin. A scholar is included among the top collaborators of David Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Baldwin. David Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increasing Lung Screening uptake: Exploring people who smoke and their family members concerns and recommendations regarding screening invitations 2025 ·Tobacco Prevention & Cessation ·(unknown), Manpreet Bains, (unknown), Emma O’Dowd, David Baldwin, Rachael L Murray	0
2	Screening for lung cancer: A systematic review of overdiagnosis and its implications 2025 ·Molecular Oncology ·(unknown), (unknown), David Baldwin, Carlijn van der Aalst, Mangesh A. Thorat, David Ritchie, André Lopes Carvalho, Carolina Espina, Iván Solà, (unknown), (unknown), Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto	1
3	European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer 2025 ·Molecular Oncology ·Mangesh A. Thorat, Marc Arbyn, David Baldwin, Xavier Castells, Solveig Hofvind, Urška Ivanuš, Carlo Senore, Esther Toes‐Zoutendijk, Carlijn van der Aalst, (unknown), (unknown), Ariadna Feliu, Hajo Zeeb, André Lopes Carvalho, (unknown), David Ritchie, Carolina Espina, Iris Lansdorp‐Vogelaar, Andrea DeCensi	1
4	Pulmonary fibrosis and lung cancer: an analysis of the Clinical Practice Research Datalink linked to the National Cancer Registration Dataset 2024 ·Thorax ·(unknown), Jaspreet Kaur, Martina Bonifazi, David Baldwin, Emma O’Dowd, Richard Hubbard	1
5	Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals 2023 ·JAMA Network Open ·Rebecca Landy, (unknown), David Baldwin, Paul F. Pinsky, Li C. Cheung, Philip E. Castle, Martin Skarzynski, Hilary A. Robbins, Hormuzd A. Katki	9
6	Important parameters for cost-effective implementation of lung cancer screening 2023 ·British Journal of Radiology ·(unknown), David Baldwin	4
7	The Impact of COVID-19 on Lung Cancer Incidence in England 2023 ·CHEST Journal ·(unknown), (unknown), (unknown), Douglas West, John Conibear, Neal Navani, Emma O’Dowd, David Baldwin, David J. Humes, Richard Hubbard	10
8	Cost-effectiveness of volume computed tomography in lung cancer screening: a cohort simulation based on Nelson study outcomes 2023 ·Journal of Medical Economics ·(unknown), (unknown), David Baldwin, Harry J.M. Groen, (unknown), James Ryan, (unknown), (unknown), Matthijs Oudkerk, Maarten J. Postma	8
9	Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD 2023 ·ERJ Open Research ·(unknown), (unknown), David Baldwin, Richard Booton, Mike Darby, (unknown), Rhian Gabe, Neil Hancock, Sam M. Janes, Martyn Kennedy, (unknown), Richard D Neal, Suzanne Rogerson, Bethany Shinkins, (unknown), (unknown), Jørgen Vestbo, Philip Crosbie, Matthew Callister	8
10	Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial 2022 ·Thorax ·N. Woznitza, (unknown), Anand Devaraj, Sam M. Janes, K. Piper, (unknown), Angshu Bhowmik, (unknown), (unknown), (unknown), (unknown), Iain Au‐Yong, (unknown), (unknown), Sarah Sheard, Stephen G. Ellis, (unknown), (unknown), Stephen W. Duffy, David Baldwin	8
11	The Future of Lung Cancer Screening: Current Challenges and Research Priorities 2022 ·SHILAP Revista de lepidopterología ·(unknown), Emma O’Dowd, David Baldwin	20
12	Implementing Lung Cancer Screening in Europe: Taking a Systems Approach 2022 ·JTO Clinical and Research Reports ·Suzanne Wait, Arturo Álvarez-Rosete, Tasnime Osama, (unknown), Robin Cornelissen, (unknown), Pilar Garrido, Mariusz Adamek, Jan P. van Meerbeeck, Annemiek Snoeckx, O. Leleu, (unknown), S. Couraud, David Baldwin	38
13	Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials 2019 ·American Journal of Respiratory and Critical Care Medicine ·Samantha L. Quaife, Mamta Ruparel, Jennifer Dickson, Rebecca J. Beeken, Andy McEwen, David Baldwin, Angshu Bhowmik, Neal Navani, Karen Sennett, Stephen W. Duffy, Jane Wardle, Jo Waller, Sam M. Janes	77
14	Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial 2017 ·Trials ·N. Woznitza, Anand Devaraj, Sam M. Janes, Stephen W. Duffy, Angshu Bhowmik, (unknown), K. Piper, (unknown), David Baldwin	15
15	Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention 2016 ·BMJ Open ·N. Bayman, David Ardron, Linda Ashcroft, David Baldwin, Richard Booton, Liz Darlison, John Edwards, (unknown), J.F. Lester, Michael Peake, Robert C. Rintoul, M. Snee, Paul Taylor, (unknown), Corinne Faivre‐Finn	16
16	Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data 2016 ·British Journal of Cancer ·Alex J Walker, David Baldwin, Tim Card, Helen Powell, Richard Hubbard, Matthew J. Grainge	64
17	Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial 2015 ·BMJ Open ·(unknown), Kate Lifford, Ben Carter, Fiona E. McRonald, Ghasem Yadegarfar, David Baldwin, David Weller, David M. Hansell, Stephen W. Duffy, John K. Field, Kate Brain	143
18	Patients’ attitudes to risk in lung cancer surgery: A qualitative study 2015 ·Lung Cancer ·(unknown), Laura Jones, David Baldwin, (unknown), RB Hubbard, (unknown), Laila J. Tata, (unknown), Manpreet Bains	14
19	Effect of Diuretics on Allergen-Induced Contractions of Passively Sensitized Human Bronchi In Vitro 1995 ·American Journal of Respiratory and Critical Care Medicine ·Ian Pavord, Elaine Holland, David Baldwin, Anne E. Tattersfield, Alan J. Knox	8
20	Respiratory profiles of grain handlers and sedentary workers. 1981 ·PubMed Central ·F. A. Herbert, (unknown), E. Schram, David Baldwin	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact